{"id":555857,"date":"2026-06-13T12:30:00","date_gmt":"2026-06-13T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=555857"},"modified":"2026-05-11T09:46:38","modified_gmt":"2026-05-11T07:46:38","slug":"signos-de-mejora-de-la-tolerabilidad-con-el-tratamiento-prolongado","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/signos-de-mejora-de-la-tolerabilidad-con-el-tratamiento-prolongado\/","title":{"rendered":"Signos de mejora de la tolerabilidad con el tratamiento prolongado"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Ozanimod, un modulador selectivo de los receptores 1 y 5 de la esfingosina-1-fosfato (S1P), ha demostrado su eficacia en la esclerosis m\u00faltiple remitente-recurrente (EMR) en estudios de fase 2 y 3. A una dosis de 0,92 mg al d\u00eda, demostr\u00f3 una eficacia superior en comparaci\u00f3n con el interfer\u00f3n \u03b2-1a intramuscular tanto en los criterios de valoraci\u00f3n cl\u00ednicos como en las medidas de actividad de la enfermedad obtenidas por resonancia magn\u00e9tica, al tiempo que manten\u00eda un perfil de tolerabilidad favorable con menos acontecimientos adversos y bajas tasas de interrupci\u00f3n. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fsignos-de-mejora-de-la-tolerabilidad-con-el-tratamiento-prolongado%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Ozanimod, un modulador selectivo de los receptores 1 y 5 de la esfingosina-1-fosfato (S1P), ha demostrado su eficacia en la esclerosis m\u00faltiple remitente-recurrente (EMR) en estudios de fase 2 y&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fsignos-de-mejora-de-la-tolerabilidad-con-el-tratamiento-prolongado%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555858,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Ozanimod para la esclerosis m\u00faltiple remitente-recurrente","footnotes":""},"category":[11552,11475,11408,11478,11328],"tags":[12343,35905,91864,28304,91867],"powerkit_post_featured":[],"class_list":["post-555857","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-estudios","category-farmacologia-y-toxicologia","category-formacion-continua","category-neurologia","tag-esclerosis-multiple","tag-ozanimod-es","tag-receptor-de-esfingosina-1-fosfato","tag-rms-es","tag-s1p","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-27 04:34:09","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=555857"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555857\/revisions"}],"predecessor-version":[{"id":555859,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/555857\/revisions\/555859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/555858"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=555857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=555857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=555857"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=555857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}